More reads
- How Joe Grogan, a former pharma lobbyist, upended Trump’s drug pricing agenda. (STAT)
- Seattle Genetics breast cancer pill delayed tumor growth in Phase 3 trial. (STAT Plus)
- Baker Brothers makes $730 million in one day on its biotech bet. (Bloomberg)
- New CRISPR tool has the potential to correct almost all disease-causing DNA glitches, scientists report. (STAT)
.png)
No hay comentarios:
Publicar un comentario